Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

2.2K
This study used in-silico strategies to identify Enumerated Etravirine as a promising therapeutic agent for HIV. Our findings on molecular interactions and dynamics support the rational design of novel NNRTIs as possible HIV treatment...
2.2K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

15.2K
Emergence of genetic resistance against kinase inhibitor therapy poses significant challenge for effective cancer therapy. Identification and characterization of resistant mutations against a newly developed drug helps in better clinical management and next generation drug design. Here, we describe our protocol for in vitro screening and validation of resistant...
15.2K
Advanced Self-Healing Asphalt Reinforced by Graphene Structures: An Atomistic Insight08:03

Advanced Self-Healing Asphalt Reinforced by Graphene Structures: An Atomistic Insight

5.6K
Graphene-modified asphalt nanocomposite has shown an advanced self-healing ability compared to pure asphalt. In this protocol, molecular dynamics simulations have been applied in order to understand the role of graphene in the self-healing process and to explore the self-healing mechanism of asphalt components from the atomistic...
5.6K
An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

8.7K
We developed an in vitro model of dormancy in the bone marrow for estrogen-sensitive breast cancer cells. The goal of this protocol is to demonstrate use of the model for the study of the molecular and cellular biology of dormancy and for generation of hypotheses for subsequent testing in vivo.
8.7K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

7.6K
This is a time- and cost-effective in vitro protocol investigating the mechanisms of acquired resistance to targeted therapeutic agents, which is a highly unmet medical need in cancer...
7.6K
Molecular Structure and Acidity02:34

Molecular Structure and Acidity

20.4K
An acid can be deprotonated to form a conjugate base or an anion. If the produced anion is more stable, then the acid is stronger. On the contrary, if the anion is unstable, then the acid is weaker. Hence, to determine the acidity of the compound, the stability of its conjugate base is studied using various factors.
The size effect explains the change in atomic size on acidity. When comparing the acids formed from elements that belong to the same column in the periodic table, their atomic sizes...
20.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRPV4: A Promising Therapeutic Target Ion Channel─Discovery of Ultrapotent Selective Antagonists.

Journal of medicinal chemistry·2026
Same author

Quo vadis, BGA? A collaborative EDNAP exercise on the challenges and progress in forensic biogeographical ancestry inference.

Forensic science international. Genetics·2026
Same author

Discovery of CNS Penetrant SOS1 Inhibitors for the Treatment of KRAS-Dependent Cancers.

Journal of medicinal chemistry·2026
Same author

Discovery of Novel Ionizable Lipids for Lipid Nanoparticles: Lipophilicity as a Predictor of Squaramide Head Group Lipid Clearance.

Small science·2026
Same author

Correction to "Targeting the Interaction of NRF2 and β-TrCP with Molecular Glues".

ACS chemical biology·2026
Same author

Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa.

Molecular therapy. Advances·2026

Related Experiment Video

Updated: Jan 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K

Structural and Molecular Insight into Resistance Mechanisms of First Generation cMET Inhibitors.

Gavin W Collie1, Cheryl M Koh2, Daniel J O'Neill1

  • 1Discovery Sciences, R&D, AstraZeneca, Cambridge, U.K.

ACS Medicinal Chemistry Letters
|September 19, 2019
PubMed
Summary

Understanding the cMET D1228V mutation is crucial for cancer treatment. This study reveals how this mutation affects small molecule inhibitor binding, guiding future drug design for resistant cancers.

More Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.2K
Advanced Self-Healing Asphalt Reinforced by Graphene Structures: An Atomistic Insight
08:03

Advanced Self-Healing Asphalt Reinforced by Graphene Structures: An Atomistic Insight

Published on: May 31, 2022

5.6K

Related Experiment Videos

Last Updated: Jan 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.2K
Advanced Self-Healing Asphalt Reinforced by Graphene Structures: An Atomistic Insight
08:03

Advanced Self-Healing Asphalt Reinforced by Graphene Structures: An Atomistic Insight

Published on: May 31, 2022

5.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Structural Biology

Background:

  • Small molecule inhibitors targeting the cMET receptor tyrosine kinase are used in cancer therapy.
  • Emerging resistance-conferring mutations in cMET necessitate molecular-level understanding.
  • Specific mutations like D1228V impact drug efficacy and require detailed investigation.

Purpose of the Study:

  • To elucidate the molecular mechanisms of cMET resistance mutations.
  • To characterize the structural basis of small molecule inhibitor recognition by the D1228V cMET mutant.
  • To provide insights for the design of next-generation cMET inhibitors.

Main Methods:

  • X-ray crystallography to determine the structures of wild-type and D1228V cMET mutants bound to inhibitors.
  • Biochemical assays to assess kinase activity and inhibitor potency.
  • Biophysical techniques to analyze protein-ligand interactions.
  • Cellular assays to evaluate drug response in the context of the mutation.

Main Results:

  • First crystal structures of the clinically relevant cMET D1228V resistance mutant complexed with small molecule inhibitors.
  • Crystal structure of wild-type cMET bound to the clinical inhibitor savolitinib.
  • The D1228V mutation induces significant conformational changes in the cMET kinase domain.
  • Demonstrated impact of the mutation on small molecule binding and inhibitor efficacy.

Conclusions:

  • The D1228V mutation alters cMET conformation, affecting small molecule inhibitor binding.
  • Structural insights into the D1228V mutant provide a basis for rational drug design.
  • This research advances the understanding of cMET-mediated resistance and informs future therapeutic strategies.